Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W Leisenring
Treatment of Fanconi Anemia Patients Using Fludarabine and Low-Dose TBI, Followed by Unrelated Donor Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Stem Cell Transplantation for Patients With Fanconi Anemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcomes From Unrelated Donor Hematopoietic Stem Cell Transplantation
Cancer Control
Medicine
Oncology
Hematology
Successful Treatment of Griscelli Syndrome With Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
A Fludarabine-Based Dose-Reduced Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation From Related or Unrelated Donors in Patients With Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
Hematopoietic Stem Cell Transplantation in Fanconi Anemia: Experience Pediatric Transplant Unit
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation
Science Translational Medicine
Medicine
Reduced-Intensity Conditioning Using Fludarabine With Either Antithymocyte Globulin and BU, or Low-Dose TBI Allowing Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation Using Fludarabine–melphalan Conditioning for Treatment of Mature T-Cell Lymphomas
Bone Marrow Transplantation
Transplantation
Hematology